Technical analysis of Balchem Corp (BCPC): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry.
Price Performance
| 1 month | +4.10% |
| 3 months | +1.69% |
| Year-to-date | +11.11% |
| 1 year | +11.09% |
| 3 years | +46.02% |
| 5 years | +12.11% |
| 10 years | +130.58% |
52-Week Range
| 52-week High | $183.90 |
| 52-week Low | $147.18 |
| Avg Volume (90d) | 223K |
Technical Indicators
| SMA 50 | $170.36 |
| SMA 200 | $169.21 |
| Beta | 0.95 |
| 30-day Volatility (annualised) | 18.6% |
| Price vs SMA 50 | +0.0% |
| Price vs SMA 200 | +0.7% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $153.36 | |
| 2026-01 | $170.17 | +11.0% |
| 2026-02 | $181.43 | +6.6% |
| 2026-03 | $169.48 | -6.6% |
| 2026-04 | $161.62 | -4.6% |
| 2026-05 | $156.73 | -3.0% |
| 2026-06 | $168.95 | +7.8% |
| 2026-07 | $167.56 | -0.8% |
| 2026-08 | $175.89 | +5.0% |
| 2026-09 | $164.96 | -6.2% |
| 2026-10 | $170.40 | +3.3% |
| 2026-10 | $170.40 | +0.0% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2027-02-19 | $1.41 | $287M |
| 2026-10-23 | $1.43 | $289M |
| 2026-07-31 | $1.27 | $269M |
| 2026-04-30 | $1.33 | $267M |
| 2026-02-20 | $1.29 | $260M |
| 2025-10-21 | $1.36 | $260M |
| 2025-07-31 | $1.25 | $258M |
Price
| Price | $169.98 (closing price, October 30, 2026) |
| Market Cap | $5.4B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 33.46 |
| Price / Book | 4.10 |
| EV / EBITDA | 20.03 |
| Dividend Yield | 0.56% |
Financial Health
| Debt / Equity | 0.11 |
| Current Ratio | 2.47 |
| Piotroski F-Score | 8 |
| Altman Z-Score | 8.75 |